Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: a systematic review with meta-analysis

Background: The rapidly evolving coronavirus disease 2019 (COVID-19) has resulted in more than 24 million infections and 821 thousand deaths. However, a vaccine or specific drug is absent up to this date and more attention has been focused on the use of convalescent plasma (CP). Several articles hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenjing, Luo, Yuanzheng, Feng, Li, Jun-Ying, Tang, Liang V., Yu, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835046/
https://www.ncbi.nlm.nih.gov/pubmed/33323550
http://dx.doi.org/10.18632/aging.202195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835046/
https://www.ncbi.nlm.nih.gov/pubmed/33323550
http://dx.doi.org/10.18632/aging.202195

Ejemplares similares